Sign in with Google. Opens in new tab
bullish

Upstream Bio

Upstream Bio Valuation Summary, DCF Analysis Suggests U.S. Business (Ex. COPD) Is Worth ~$1.8B

489 Views28 Sep 2024 17:41
In my insight, I discuss DCF valuation for biotech company Upstream Bio ahead of upcoming IPO, which is expected to be priced in October
What is covered in the Full Insight:
  • Introduction
  • IPO Summary
  • Verekitug Competitive Landscape
  • Revenue Projections
  • DCF Analysis
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
x